Bloomage Biotechnology Co (China) Performance
| 688363 Stock | 49.60 0.85 1.68% |
The firm shows a Beta (market volatility) of -0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Bloomage Biotechnology Co are expected to decrease at a much lower rate. During the bear market, Bloomage Biotechnology Co is likely to outperform the market. At this point, Bloomage Biotechnology Co has a negative expected return of -0.0796%. Please make sure to confirm Bloomage Biotechnology Co's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Bloomage Biotechnology Co performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bloomage Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Bloomage Biotechnology Co is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Payout Ratio 0.4176 | Ex Dividend Date 2024-08-08 |
1 | Bloomage BioTechnology Might Be Having Difficulty Using Its Capital Effectively - Simply Wall St | 03/19/2025 |
| Begin Period Cash Flow | 1.2 B |
Bloomage |
Bloomage Biotechnology Co Relative Risk vs. Return Landscape
If you would invest 5,242 in Bloomage Biotechnology Corp on December 29, 2024 and sell it today you would lose (282.00) from holding Bloomage Biotechnology Corp or give up 5.38% of portfolio value over 90 days. Bloomage Biotechnology Corp is generating negative expected returns and assumes 1.7873% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Bloomage, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bloomage Biotechnology Co Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bloomage Biotechnology Co's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bloomage Biotechnology Corp, and traders can use it to determine the average amount a Bloomage Biotechnology Co's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0445
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688363 |
Estimated Market Risk
| 1.79 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bloomage Biotechnology Co is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bloomage Biotechnology Co by adding Bloomage Biotechnology Co to a well-diversified portfolio.
Bloomage Biotechnology Co Fundamentals Growth
Bloomage Stock prices reflect investors' perceptions of the future prospects and financial health of Bloomage Biotechnology Co, and Bloomage Biotechnology Co fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bloomage Stock performance.
| Return On Equity | 0.0234 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 23.65 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Price To Book | 3.40 X | ||||
| Price To Sales | 4.45 X | ||||
| Revenue | 6.08 B | ||||
| Gross Profit | 5.37 B | ||||
| EBITDA | 411.58 M | ||||
| Net Income | 592.56 M | ||||
| Total Debt | 153.13 M | ||||
| Book Value Per Share | 14.67 X | ||||
| Cash Flow From Operations | 699.65 M | ||||
| Earnings Per Share | 0.91 X | ||||
| Total Asset | 8.47 B | ||||
| Retained Earnings | 2.45 B | ||||
About Bloomage Biotechnology Co Performance
By analyzing Bloomage Biotechnology Co's fundamental ratios, stakeholders can gain valuable insights into Bloomage Biotechnology Co's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bloomage Biotechnology Co has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bloomage Biotechnology Co has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bloomage BiotechnologyCo is entity of China. It is traded as Stock on SHG exchange.Things to note about Bloomage Biotechnology Co performance evaluation
Checking the ongoing alerts about Bloomage Biotechnology Co for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bloomage Biotechnology Co help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bloomage Biotechnology Co generated a negative expected return over the last 90 days | |
| About 60.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Bloomage BioTechnology Might Be Having Difficulty Using Its Capital Effectively - Simply Wall St |
- Analyzing Bloomage Biotechnology Co's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bloomage Biotechnology Co's stock is overvalued or undervalued compared to its peers.
- Examining Bloomage Biotechnology Co's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bloomage Biotechnology Co's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bloomage Biotechnology Co's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bloomage Biotechnology Co's stock. These opinions can provide insight into Bloomage Biotechnology Co's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bloomage Stock analysis
When running Bloomage Biotechnology Co's price analysis, check to measure Bloomage Biotechnology Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomage Biotechnology Co is operating at the current time. Most of Bloomage Biotechnology Co's value examination focuses on studying past and present price action to predict the probability of Bloomage Biotechnology Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomage Biotechnology Co's price. Additionally, you may evaluate how the addition of Bloomage Biotechnology Co to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |